Key result
Immediate multivessel PCI linked to ~3-fold higher 30-day major cardiovascular events vs staged in-hospital PCI.
Why the study?
In patients with AMI and multivessel disease without shock, the optimal timing of intervention for non-culprit lesions and the effect of coronary lesion complexity assessed by the Syntax score on timing remained a matter of debate.
Does immediate multivessel intervention compared to staged intervention during index hospitalization reduce 30-day MACE in patients with acute myocardial infarction and multivessel disease?
Observational (n=605)
No
Does immediate multivessel intervention compared to staged intervention during index hospitalization reduce 30-day MACE in patients with acute myocardial infarction and multivessel disease?
In patients with acute myocardial infarction and multivessel disease, staged complete revascularization during the index hospitalization is associated with lower 30-day MACE compared to immediate complete revascularization at the time of the index PCI.
Answers are grounded in this paper and cite their sources.
Staged in-hospital PCI may lower 30-day MACE versus immediate multivessel PCI in AMI; leaves open optimal timing pending randomized confirmation.
Background and objective: In patients with acute myocardial infarction and multivessel disease, the timing of intervention to non-culprit lesions is still a matter of debate, especially in patients without shock. This study aimed to compare the effect of multivessel intervention, performed at index percutaneous coronary intervention (PCI) (MVI-I) or index hospitalization (MVI-S), on the 30-day results of acute myocardial infarction (AMI), and to investigate the effect of coronary lesion complexity assessed by the Syntax (Sx) score on the timing of multivessel intervention. Materials and methods: We enrolled 180 patients with MVI-I, and 425 patients with MVI-S. The major adverse cardiovascular events (MACE) for this study were identified as mortality, nonfatal myocardial infarction, nonfatal stroke, acute heart failure, ischemia driven revascularization, major bleeding, and acute renal failure developed within 30 days. Results: The unadjusted MACE rates at 30 days were 11.2% and 5% among those who underwent MVI-I and MVI-S, respectively (OR 3.02; 95% confidence interval (CI) 1.51–6.02; p = 0.002). Associations were statistically significant after adjusting for covariates in the penalized multivariable model (adjusted OR 2.06; 95%CI 1.02–4.18; p = 0.043), propensity score adjusted multivariable model (adjusted OR 2.46; 95%CI 1.19–5.07; p = 0.015), and IPW (adjusted OR 2.11; 95%CI 1.28–3.47; p = 0.041). We found that the Syntax score of lesions did not affect the results. Conclusion: MVI-S was associated with a lower incidence of major adverse cardiovascular events within 30 days after discharge.
No takes yet. Share an insight, caveat, or question.
Doğan et al. (2019) conducted an observational in Acute myocardial infarction with multivessel disease (n=605). Immediate multivessel intervention at index PCI (MVI-I) vs. Staged multivessel intervention at index hospitalization (MVI-S) was evaluated on Major adverse cardiovascular events (MACE: cardiovascular mortality, nonfatal MI, nonfatal stroke, acute heart failure, ischemia-driven revascularization, major bleeding, and acute renal failure) within 30 days after discharge (OR 3.02, 95% CI 1.51-6.02, p=0.002). Immediate multivessel PCI increased 30-day major cardiovascular events compared to staged in-hospital PCI in AMI patients with multivessel disease.
Synapse has enriched 10 related papers. Consider them for comparative context: